EX-10.7



 Exhibit 10.7 

AMENDED AND RESTATED EMPLOYMENT AND NON-COMPETITION 

AGREEMENT 
 This
AMENDED AND RESTATED EMPLOYMENT AND NON-COMPETITION AGREEMENT (this “Agreement”) is effective as of April 25, 2017 (the “Effective Date”), by and between Addus HealthCare, Inc., an Illinois corporation (the
“Company”), and Brenda Belger, an individual domiciled in the State of Texas (the “Executive”). 

WHEREAS, the Company, its parent and its subsidiaries (collectively, the “Addus HealthCare Group”) provide home care services
to individuals, county and state governments, health maintenance organizations, independent physician associations, insurance companies, facilities, other business purchasers of such services, and to the general public at large. 

WHEREAS, the Executive is currently employed by the Company as its Chief Human Resources Officer pursuant to an Employment and
Non-Competition Agreement dated June 1, 2016 (the “Original Date”) (the “Prior Agreement”), and the parties hereto desire to enter this Agreement to secure the Executive’s continued employment, all on the terms and
conditions set forth herein. 
 WHEREAS, by virtue of the Executive’s employment by the Company pursuant to the terms hereof,
the Executive will obtain and become familiar with certain valuable confidential and proprietary information relating to the Addus HealthCare Group, its customers and employees. 

WHEREAS, the Company desires to protect the goodwill and all proprietary rights and information of the Addus HealthCare Group. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the parties hereto, intending to be legally
bound, agree as follows: 
  

	 	1.	Effectiveness; Term of Employment.  

  

	 	(a)	This Agreement shall automatically become effective on the Effective Date. 

  

	 	(b)	 The Company hereby employs the Executive, and the Executive hereby accepts employment by the Company, for the
period commencing as of the Original Date and ending on the fourth (4th) anniversary of the Original Date, or on such earlier date as provided pursuant to the terms and conditions of this Agreement (the “Initial Employment
Term”). At the end of the Initial Employment Term, this Agreement shall automatically renew for successive one (1) year terms (each, as may be earlier terminated pursuant to the terms and conditions of this Agreement, an
“Additional Employment Term” and, together with the Initial Employment Term, as may be earlier terminated pursuant to the terms and conditions of this Agreement, the “Employment Term”), unless either party provides
notice to the other of its or her intention not to renew this Agreement at least thirty (30) days prior to the expiration of the Initial 



  
 1 









	 	
Employment Term or any Additional Employment Term (a “Non-Renewal”). During the Employment Term, the Executive shall (i) devote substantially all of her professional time,
loyalty and efforts to discharge her duties hereunder on a timely basis; (ii) use her best efforts to loyally and diligently serve the business and affairs of the Addus HealthCare Group; and (iii) endeavor in all respects to promote,
advance and further the Addus HealthCare Group’s interests in all matters. 

  

	 	2.	Employment Duties.  

 During the Employment Term, the Company will employ the
Executive as its Chief Human Resources Officer, a senior executive position that reports directly to the President and Chief Executive Officer (the “CEO”) of the Company. The Executive’s principal duties and responsibilities shall be
those reflected in the employment description set forth on Exhibit A hereto. 
  

	 	3.	Compensation.  

 The Company will pay the Executive as follows during the
Employment Term: 
  

	 	(a)	Base Salary. Commencing March 5, 2017, the Company shall pay the Executive a base salary at the annual rate of Two Hundred Seventy Five Thousand Dollars ($275,000), which shall be paid in accordance
with the normal payroll practices of the Company and shall be subject to applicable withholdings and deductions. Thereafter, the Executive’s base salary shall be subject to review and adjustment upward by the compensation committee (the
“Compensation Committee”) of the board of directors of Addus HomeCare Corporation (“Addus HomeCare”) (the “Board of Directors”) on or about each anniversary of the Effective Date for each year
during the Employment Term (as adjusted from time-to-time, the “Base Salary”). 

  

	 	(b)	Bonus. The Executive, at the discretion of the Compensation Committee, shall be eligible (but not entitled) to receive an annual bonus as set forth on Exhibit B hereto. The Compensation Committee,
at its sole discretion, may determine the amount of the annual bonus, if any, to which the Executive may become entitled based on the quantitative and qualitative factors described on Exhibit B or any other factors the Compensation Committee
may deem appropriate from time to time. All amounts payable pursuant to this Section 3(b), if any, shall be paid within no more than thirty (30) days after completion of Addus HomeCare’s audited financial statements for the most
recently completed fiscal year, but in all events, in the fiscal year following the fiscal year in which it was earned, and shall be subject to applicable withholdings and deductions. Bonus is not salary and is earned on the day it is paid. To be
eligible to receive the bonus, the Executive must be actively employed and must not have given notice of termination on or prior to such date. 


  
 2 









	 	(c)	Options. The Executive has previously received equity awards pursuant to the Prior Agreement. 

  

	 	4.	Expenses.  

 It is recognized that the Executive in the performance of her duties
hereunder may be required to expend sums for travel (e.g., airfare, automobile rental, etc.), entertainment and lodging. During the Employment Term, the Company shall reimburse the Executive for reasonable business expenses incurred by her during
the Employment Term in connection with the performance of her duties hereunder conditioned upon and subject to the Company’s established policies and procedures, including written receipt from the Executive of an itemized accounting in
accordance with the Company’s regular business expense verification practices. Such policies shall also be in effect for frequent travel by the Executive to the Company’s Corporate Center which it is agreed shall be as needed and
commensurate with the Executive’s duties and responsibilities during her employment hereunder; such time spent onsite at the Corporate Center may vary from time to time depending on the Executive’s tenure and the results of the Company.

  

	 	5.	Benefits.  

 During the Employment Term, the Executive shall be entitled to
benefits under such plans, programs or arrangements as the Board of Directors may establish or maintain from time to time for similarly-situated employees, and in accordance with its policies, which may change at the sole discretion of the Board of
Directors. Benefits as of the Effective Date are: 
  

	 	(a)	Four (4) weeks paid vacation during each year of employment. Subject to the Company’s established policies and procedures, vacation may be carried over to a subsequent year of employment, not to exceed eight
(8) weeks during any calendar year of employment. 

  

	 	(b)	Five (5) days personal/sick leave per year, with pay. Personal/sick days may be carried over to a subsequent year of employment, not to exceed ten (10) days during any calendar year of employment.


  

	 	(c)	Six (6) Company holidays, plus two (2) floating holidays, per year. 

  

	 	(d)	Coverage beginning on the Original Date under the health benefit plan provided by the Company to its executives, which may change, at the sole discretion of the Board of Directors, from time to time. The Company will
cover the Executive and her dependents, if any, during the Employment Term to the same extent and according to the same terms as the Company’s other executives are covered. 


 

	 	(e)	Life insurance policy beginning on the Original Date with a face amount of up to five (5) times the Base Salary, provided that the Company shall not be required to spend greater than three percent (3%) of the
Base Salary in purchasing such insurance policy. 


  
 3 









	 	(f)	Short-term and long-term disability insurance beginning on the Original Date to the same extent and according to the same terms as the Company’s other similarly-situated executives are covered, which may change, at
the sole discretion of the Board of Directors, from time to time. 

  

	 	(g)	Tuition reimbursement shall be available for courses relevant to the Executive’s position and taken at an accredited institution, subject to prior approval by the Board of Directors. 


 

	 	(h)	Participation in the Company’s 401(k) plan up to the defined Internal Revenue Service limit beginning 30 days after the Original Date. The Company will annually match 6% of the Executive’s annual contribution
to such plan during the Employment Term, subject to the Company’s established policies and procedures. 

  

	 	6.	Termination by Company.  

  

	 	(a)	The Company may terminate the Executive’s employment hereunder at any time for Reasonable Cause. The term “Reasonable Cause” shall be limited to the following: 


(i) A material breach or omission by the Executive of any of her duties or obligations under this Agreement (except due to Disability, as
defined below) that the Executive shall fail to cure after receipt of written notice of such breach or omission from the Company’s CEO or Board of Directors, which notice shall designate the period of time within which the breach or omission
must be cured to the satisfaction of the CEO or the Board of Directors, as applicable, in order to prevent a termination for Reasonable Cause; provided, however, that the Executive shall only be permitted the opportunity to cure such breaches or
omissions a total of two times in any twelve (12)-month rolling period; 
 (ii) The Executive shall willfully engage in any action that
materially damages, or that may reasonably be expected to materially damage, the Addus HealthCare Group or the business or goodwill thereof; 

(iii) The Executive shall breach her fiduciary duty to the Addus HealthCare Group; 

(iv) The Executive shall commit any act involving fraud, the misuse or misappropriation of money or other property of the Addus HealthCare
Group, a felony, habitual use of drugs or other intoxicants or chronic absenteeism; 
 (v) Gross negligence or willful misconduct by the
Executive; 

  
 4 








 (vi) The Executive shall commit acts constituting gross insubordination, such as, without
limitation, the intentional disregard of any reasonable directive of the CEO or the Board of Directors; 
 (vii) The Executive shall fail to
perform any material duty in a timely and effective manner and shall fail to cure any such performance deficiency after receipt of written notice of the deficiency from the CEO or Board of Directors, which notice shall designate the period of time
within which the performance deficiency must be cured to the satisfaction of the CEO or the Board of Directors, as applicable, in order to prevent a termination for reasonable cause; provided, however, that the Executive shall only be permitted the
opportunity to cure performance deficiencies a total of two times in any twelve (12)-month rolling period; or 
  

	 	(b)	The Executive’s employment hereunder shall be terminated in the event of her death, and the Company may terminate the Executive’s employment hereunder if the Executive suffers a physical or mental disability
(a “Disability”) so that the Executive is or, in the opinion of an independent physician retained by the Company for purposes of this determination will be, unable to perform her duties in a manner satisfactory to the Company for a
period of ninety (90) days out of any one hundred eighty (180) consecutive-day period (in which event the Executive shall be deemed to have suffered a permanent Disability). 


 

	 	(c)	The Company may terminate the Executive’s employment hereunder at any time for any other reason, or for no reason. 

  

	 	(d)	Termination of the Executive’s employment for any reason shall terminate the Employment Term but shall not affect the Executive’s obligations pursuant to Section 9 hereof, which obligations shall remain
in effect for the period therein provided. 

  

	 	7.	Termination by the Executive.  

 The Executive may terminate her employment with
the Company (a) for Good Reason (as defined below) or (b) without Good Reason, in each case, upon not less than thirty (30) days prior written notice to the Company; provided, however, that after the receipt of such notice, the
Company may, in its discretion accelerate the effective date of such termination at any time by written notice to the Executive. Termination of the Executive’s employment by the Executive shall terminate the Employment Term, but shall not
affect the Executive’s obligations under Section 9 hereof, which obligations shall remain in effect for the period therein provided. As used herein, “Good Reason” means (i) any reduction in the Executive’s Base
Salary, (ii) any material reduction to the Executive’s employment duties and responsibilities, (iii) any willful breach by the Company of any material term of this Agreement, other than a breach which is remedied by the Company within
10 days after receipt of written notice given by the Executive, or (iv) a change in the Executive’s direct reporting duty to a person other than the Chief Executive Officer of the Company or the Board of Directors. 

  
 5 









	 	8.	Rights and Obligations Upon Termination.  

  

	 	(a)	If the Executive’s employment is terminated by the Company pursuant to Section 6(a) or 6(b) hereof or by the Executive pursuant to Section 7(b) hereof, the Executive or her estate shall have no further
rights against the Addus HealthCare Group hereunder, except for the right to receive, with respect to the period prior to the effective date of termination: 


(i) Any unpaid Base Salary under Section 3(a) hereof for any period prior to the effective date of termination; 

(ii) Any accrued but unpaid benefits under Section 5 hereof for any period prior to the effective date of termination; and 

(iii) In the case of termination pursuant to Section 6(b), eligibility for life or disability insurance benefits described in Sections
5(e) or (f), as applicable. 
 Such payments shall be made to the Executive whether or not the Company chooses to utilize the services of
the Executive for the required notice period specified in Section 7. 
  

	 	(b)	If the Executive’s employment is terminated pursuant to Section 6(c) hereof or Section 7(a) hereof, or as a result of Non-Renewal by the Company, the Executive shall be entitled to, in lieu of any further
payments to the Executive for periods subsequent to the date of termination: 

 (i) Any unpaid Base Salary under
Section 3(a) hereof for any period prior to the effective date of termination; 
 (ii) A pro rata portion of the bonus under
Section 3(b) hereof based on what Executive would have been entitled to receive pursuant to the Company’s then-effective bonus plan had her employment not been terminated, which shall be payable following the time the Company determines
the amount of bonuses payable to its executives following the end of the year in which termination occurs, which determination will be based on the actual performance of the Company; 

(iii) Any accrued but unpaid benefits under Section 5 hereof for any period prior to the effective date of termination, in
accordance with the terms of the applicable plan or arrangement; 
 (iv) Conditioned upon the Executive’s strict compliance with
the post-employment restrictions described in Section 9 below and subject to applicable withholdings and deductions, severance pay (“Base Severance Pay”) in an amount equal to the Executive’s Base Cash Compensation (as
defined below) to be paid in equal installments on the Company’s regular 

  
 6 








 
pay dates over the twelve (12) month period following termination of the Executive’s employment (subject to applicable withholdings and deductions), plus, if the Executive timely elects
to continue her health, dental and/or vision insurance coverage under COBRA, the Executive shall be eligible to receive after-tax cash payments equal to the difference between her COBRA continuation coverage premiums and the amount of premiums paid
by similarly-situated active employees of the Company under the Company’s health, dental and/or vision insurance plans, for a period of twelve (12) months following the Executive’s date of termination of employment, to be paid in
equal installments on the Company’s regular pay dates (subject to applicable tax withholdings and deductions). 
 For purposes of this
Agreement, “Base Cash Compensation” shall mean the highest annual Base Salary in effect for the Executive. 
  

	 	(c)	 Notwithstanding anything to the contrary set forth herein, if the Executive’s employment is terminated by
the Company pursuant to Section 6(c) within six (6) months prior to, or one (1) year following, a Change in Control (as defined below), the Executive shall be entitled to, in lieu of the payments to be made pursuant to
Section 8(b)(iv), an amount equal to the Executive’s Annual Cash Compensation (as defined below) (subject to applicable withholdings and deductions), less any payment already received pursuant to Section 8(b)(iv) (“Change of
Control Severance Pay” and, together with Base Severance Pay, “Severance Pay”), which shall be payable in accordance with the normal payroll practices of the Company in equal installments on the Company’s regular pay
dates for one (1) year following termination of the Executive’s employment, plus, if the Executive elects to continue her health, dental and/or vision insurance coverage under COBRA, the Executive shall be eligible to receive after-tax
cash payments equal to the difference between her COBRA continuation coverage premiums and the amount of premiums paid by similarly-situated active employees of the Company under the Company’s health, dental and/or vision insurance plans,
payable in equal installments on the Company’s regular pay dates (subject to applicable tax withholdings and deductions) until one (1) year following the termination of the Executive’s employment. As used herein, a “Change in
Control” shall be deemed to have occurred if (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), other than a trustee
or other fiduciary holding securities under an employee benefit plan of Addus HomeCare, or a corporation owned directly or indirectly by the stockholders of Addus HomeCare in substantially the same proportions as their ownership of stock of Addus
HomeCare, becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of Addus HomeCare representing more than 50% of the total voting power represented by Addus HomeCare’s
then outstanding securities that vote 



  
 7 








 
generally in the election of directors (referred to herein as “Voting Securities”); or (ii) after the date of this Agreement, the stockholders of Addus HomeCare approve
(x) a merger or consolidation of Addus HomeCare with any other corporation, other than a merger or consolidation that would result in the Voting Securities of Addus HomeCare outstanding immediately prior thereto continuing to represent (either
by remaining outstanding or by being converted into Voting Securities of the surviving entity) more than 50% of the total voting power represented by the Voting Securities of Addus HomeCare or such surviving entity outstanding immediately after such
merger or consolidation, or (y) a plan of complete liquidation of Addus HomeCare or an agreement for the sale or disposition by Addus HomeCare of (in one transaction or a series of transactions) all or substantially all of Addus HomeCare’s
assets. 
 For purposes of this Agreement, “Annual Cash Compensation” shall mean the sum of (a) the highest annual
Base Salary in effect for the Executive and (b) the greater of (i) the Executive’s bonus for the most recently-completed year, if any, or (ii) the annualized amount of the Executive’s target bonus for the then current year.

  

	 	(d)	The Executive acknowledges and agrees that the Company’s obligations to make payments pursuant to Sections 8(b)(iv) and 8(c) above are expressly conditioned on the Executive timely executing, delivering and not
revoking a customary general release in form and substance satisfactory to the Company within the period that is sixty (60) days following the date of the Executive’s termination of employment or service with the Company. To the extent
that such sixty (60) day period spans two (2) calendar years, no payment of any severance amount or benefit that is (i) considered to be nonqualified deferred compensation within the meaning of Section 409A of the Internal
Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, “Code §409A”) and (ii) conditioned upon the release, shall be made before the first day of the second calendar year,
regardless of when the release is actually executed and returned to the Company. 

  

	 	9.	Covenants of the Executive.  

  

	 	(a)	No Conflicts. The Executive represents and warrants that she is not personally subject to any agreement, order or decree that restricts her acceptance of this Agreement and performance of her duties with
the Company hereunder. 

  

	 	(b)	 Non-Competition; Non-Solicitation. During the Employment Term and during the Restrictive Period (as
defined below), the Executive shall not, without the prior written consent of the Company, directly or indirectly, in 



  
 8 









	 	
any capacity whatsoever, either on her own behalf or on behalf of any other person or entity whom she may manage, control, participate in, consult with, render services for or be employed or
associated, compete with the Business (as defined below) in any of the following described manners: 

 (i) Engage in,
assist or have any interest in, as principal, consultant, advisor, agent, financier or employee, any business entity that is, or that is about to become engaged in, providing goods or services in competition with the Addus HealthCare Group within a
geographic radius of fifty (50) miles from any Addus HealthCare Group branch office; 
 (ii) Solicit or accept any business (or
help any other person solicit or accept any business) from any person or entity that on the Effective Date is a customer of the Addus HealthCare Group or during the Employment Term becomes a customer of the Addus HealthCare Group, other than a
customer that does not engage in the Business; 
 (iii) Induce or attempt to induce any employee of the Addus HealthCare Group to
terminate such employee’s relationship with the Addus HealthCare Group or in any way interfere with the relationship between the Addus HealthCare Group and any employee thereof; or 

(iv) Induce or attempt to induce any customer, referral source, supplier, vendor, licensee or other business relation of the Addus
HealthCare Group to cease doing business with the Addus HealthCare Group, or in any way interfere with the relationship between any such customer, referral source, supplier, vendor, licensee or business relation, on the one hand, and the Addus
HealthCare Group, on the other hand. 
 For purposes hereof, the term “Business” means the business of providing home care
services of the type and nature that the Addus HealthCare Group then performed and/or any other business activity in which the Addus HealthCare Group then performed or program or service then under active development proposed to be performed and/or
any other business activity in which the Addus HealthCare Group becomes engaged in on or after the date hereof while the Executive is employed by the Company. 

For purposes hereof, the term “Restrictive Period” means the period beginning on the date on which the Executive’s
employment is terminated by the Company or the Executive for any reason and ending on the first anniversary of such date. 
 Notwithstanding
the foregoing provisions, nothing herein shall prohibit the Executive from owning one percent (1%) or less of any securities of a competitor, if such securities are listed on a nationally recognized securities exchange or traded
over-the-counter. If, at the time of 

  
 9 








 
enforcement of this Section 9(b), a court holds that the restrictions stated herein are unreasonable under the circumstances then existing, the parties hereto agree that the maximum period,
scope or geographic area reasonable under such circumstances shall be substituted for the stated period, scope or area determined to be reasonable under the circumstances by such court. 

 

	 	(c)	 Non-Disclosure. The Executive recognizes and acknowledges that she will have access to certain
confidential and proprietary information of Addus HealthCare Group, including, but not limited to, Trade Secrets (as defined below) and other proprietary commercial information, and that such information constitutes valuable, special and unique
property of Addus HealthCare Group. The Executive agrees that she will not, for any reason or purpose whatsoever, except in the performance of her duties hereunder, or as required by law, disclose any of such confidential information to any person,
entity or governmental authority without express authorization of the Company. The Executive further agrees that she shall not, at any time during the Employment Term or thereafter, without the express prior written consent of the Company, directly
or indirectly, in any capacity whatsoever, either on her own behalf or on behalf of any other person or entity that she manages, controls, participates in, consults with, renders services for or is employed by or associated with, disclose or use,
except when necessary to further the interests of the Business, any Trade Secret of the Addus HealthCare Group, whether such Trade Secret is in the Executive’s memory or embodied in writing or other physical form. For purposes of this
Agreement, “Trade Secret” means any information, not generally known to, and not readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use and is the subject of efforts to
maintain its secrecy that are reasonable under the circumstances, including, but not limited to, (i) trade secrets; (ii) information concerning the business or affairs of the Addus HealthCare Group, including its products or services,
fees, costs, and pricing structures, charts, manuals and documentation, databases, accounting and business models, designs, analyses, drawings, photographs and reports, computer software, copyrightable works, inventions, devices, new developments,
methods and processes, whether patentable or unpatentable and whether or not reduced to practice, sales records and other proprietary commercial information; (iii) information concerning actual and prospective clients and customers of the Addus
HealthCare Group, including client and customer lists and other compilations; and (iv) information concerning employees, contractors and vendors of the Addus HealthCare Group, including personal information and information concerning the
compensation or other terms of employment of such individuals. “Trade Secret,” however, shall not include general “know-how” information acquired by the Executive during the course of her employment that could have been
obtained 



  
 10 









	 	
by her from public sources without the expenditure of significant time, effort and expense. 

  

	 	(d)	Covenant Regarding Confidential and Proprietary Information. The Executive will promptly disclose in writing to the Company each improvement, discovery, idea, invention, and each proposed publication of
any kind whatsoever, relating to the Business made or conceived by the Executive either alone or in conjunction with others while employed hereunder if such improvement, discovery, idea, invention or publication results from or was suggested by such
employment (whether or not patentable and whether or not made or conceived at the request of or upon the suggestion of the Company, and whether or not during her usual hours of work, whether in or about the premises of the Addus HealthCare Group and
whether prior or subsequent to the execution hereof). The Executive will not disclose any such improvement, discovery, idea, invention or publication to any person, entity or governmental authority, except to the Company. Each such improvement,
discovery, idea, invention and publication shall be the sole and exclusive property of, and is hereby assigned by the Executive to, the Company, and at the request of the Company, the Executive will assist and cooperate with the Company and any
person or entity from time to time designated by the Company to obtain for the Company or its designee the grant of any letters patent in the United States of America and/or such other country or countries as may be designated by the Company,
covering any such improvement, discovery, idea, invention or publication and will in connection therewith execute such applications, statements, assignments or other documents, furnish such information and data and take all such other action
(including, without limitation, the giving of testimony) as the Company may from time to time reasonably request. The foregoing provisions of this Section 9(d) shall not apply to any improvement, discovery, idea, invention of publication for
which no equipment, supplies, facilities or confidential and proprietary information of Addus HealthCare Group was used and that was developed entirely on the Executive’s own time, unless (x) the improvement, discovery, idea, invention or
publication relates to the Business or the actual or demonstrably anticipated research or development of the Business, or (y) the improvement, discovery, idea, invention or publication results from any work performed by the Executive for the
Addus HealthCare Group. 

  

	 	(e)	Non-Disparagement. The Executive agrees that, during the Employment Term and the Restrictive Period, she will not make any statement, either in writing or orally, that is communicated publicly or is
reasonably likely to be communicated publicly and that is reasonably likely to disparage or otherwise harm the business or reputation of the Addus HealthCare Group, or the reputation of any of its current or former directors, officers, employees or
stockholders. 


  
 11 









	 	(f)	Return of Documents and Other Property. Upon termination of employment, the Executive shall return all originals and copies of books, records, documents, customer lists, sales materials, tapes, keys,
credit cards and other tangible property of Addus HealthCare Group within the Executive’s possession or under her control. 

  

	 	(g)	Remedies for Breach. In the event of a breach or threat of a breach of the provisions of this Section 9, the Executive hereby acknowledges that such breach or threat of a breach will cause the Company
to suffer irreparable harm and that the Company shall be entitled to an injunction restraining the Executive from breaching such provisions; but the foregoing shall not be construed as prohibiting the Company from having available to it to any other
remedy, either at law or in equity, for such breach or threatened breach, including, but not limited to, the immediate cessation of employment and any remaining Severance Pay and benefits pursuant to Section 8 and the recovery of damages from
the Executive and the notification of any employer or prospective employer of the Executive as to the terms and conditions hereof (without limiting or affecting the Executive’s obligations under the other paragraphs of this Section 9).


  

	 	(h)	Acknowledgment. The Executive acknowledges that she will be directly and materially involved as a senior executive in all important policy and operational decisions of Addus HealthCare Group. The Executive
further acknowledges that the scope of the foregoing restrictions has been specifically bargained between the Company and the Executive, each being fully informed of all relevant facts. Accordingly, the Executive acknowledges that the foregoing
restrictions of this Section 9 are fair and reasonable, are minimally necessary to protect Addus HealthCare Group, its stockholders and the public from the unfair competition of the Executive who, as a result of her employment with the Company,
will have had access to the most confidential and important information of Addus HealthCare Group, its Business and future plans. The Executive furthermore acknowledges that no unreasonable harm or injury will be suffered by her from enforcement of
the covenants contained herein and that she will be able to earn a reasonable livelihood following termination of her employment notwithstanding enforcement of the covenants contained herein. 


 

	 	(i)	 Right of Set Off. In the event of a breach by the Executive of the provisions of this Agreement,
the Company is hereby authorized at any time and from time to time, to the fullest extent permitted by law, and after ten (10) days prior written notice to the Executive, to set-off and apply any and all amounts at any time held by the Company
on behalf of the Executive and all indebtedness at any time owing by the Addus HealthCare Group to the Executive against any and all of the obligations of the Executive now or hereafter existing, to the extent such set-off would




  
 12 









	 	
not result in a penalty under Code §409A with regard to amounts that are deemed deferred compensation under Code §409A. 


 

	 	10.	Prior Agreement.  

 This Agreement supersedes and is in lieu of any and all other
employment arrangements between the Executive and the Company or its predecessor or any subsidiary and any and all such employment agreements and arrangements are hereby terminated and deemed of no further force or effect. 

 

	 	11.	Assignment.  

 Neither this Agreement nor any rights or duties of the Executive
hereunder shall be assignable by the Executive and any such purported assignment by her shall be void. The Company may assign all or any of its rights hereunder. 
  

	 	12.	Notices.  

 Unless specified in this Agreement, all notices and other
communications hereunder shall be in writing and shall be deemed given upon receipt or refusal thereof if delivered personally, sent by overnight courier service, mailed by registered or certified mail (return receipt requested), postage prepaid, or
emailed to the other party’s email address on the Company’s computer network. Notice to their party hereto, if mailed or sent by overnight courier service, shall be to the following addresses: 

 

	 	(a)	if to the Executive, to: 

 Brenda Belger 

165 Lake View Circle 

Montgomery, Texas 77356 
  

	 	(b)	if to the Company, to: 

 Addus HealthCare, Inc. 

6801 Gaylord Parkway 
 Suite 110

 Frisco, TX 75034 

Attention: CEO 
 with a copy,
which shall not constitute notice, to: 

  
 13 








 Bass Berry & Sims PLC 

150 Third Avenue South 
 Suite
2800 
 Nashville, TN 37201 

Attention: David Cox, Esq. 

Telephone: (615) 742-6299 

Facsimile: (615) 742-2864 

E-mail: dcox@bassberry.com 
 Any
party may change its address for notice by giving all other parties notice of such change pursuant to this Section 12. 
  

	 	13.	Amendment.  

 This Agreement may not be changed, modified or amended except in
writing signed by both parties to this Agreement. 
  

	 	14.	Waiver of Breach.  

 The waiver by either party of the breach of any provision of
this Agreement shall not operate or be construed as a waiver of any subsequent breach by either party. 
  

	 	15.	Invalidity of Any Provision.  

 The provisions of this Agreement are severable, it
being the intention of the parties hereto that should any provision hereof be invalid or unenforceable, such invalidity or enforceability of any provisions shall not affect the remaining provisions hereof, but the same shall remain in full force and
effect as if such invalid or unenforceable provision or provisions were omitted. 
  

	 	16.	409A Compliance.  

 This Agreement is intended to comply with or be exempt from
Code §409A, and accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance with or exempt from Code §409A. Notwithstanding any other provision to the contrary, a termination of employment with the
Company shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of “deferred compensation” (as such term is defined in §409A) upon or following a termination of employment unless
such termination is also a “separation from service” from the Company within the meaning of Code §409A and Section 1.409A-1(h) of the Treasury Regulations and, for purposes of any such provision of this agreement, references to a
“separation,” “termination,” “termination of employment or like terms shall mean “separation from service.” If the Executive is a specified employee within the meaning of that term under Code §409A, then with
regard to any payment that is considered non-qualified deferred compensation under Code §409A and payable on account of a separation from service, such payment shall be made on the date which is the earlier of (i) the expiration of the six
(6)-month period measured from the date of such separation from service, and (ii) the date of the Executive’s death (the “Delay Period”) to the extent required under Code §409A. Upon the expiration of the Delay
Period, all payments delayed shall be paid to the Executive in a lump sum, and all remaining payments due under this 

  
 14 








 
Agreement shall be paid or provided for in accordance with the normal payment dates specified herein. To the extent any reimbursements or in-kind benefits under this Agreement constitute
non-qualified deferred compensation for purposes of Code §409A, (i) all such expenses or other reimbursements under this Agreement shall be made on or prior to the last day of the taxable year following the taxable year in which such
expenses were incurred by the Executive, (ii) any right to such reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit and (iii) no such reimbursement, expenses eligible for reimbursement or in-kind
benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year. For purposes of Code §409A, the Executive’s right to receive any
installment payment pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. In no event shall any payment under this Agreement that constitutes non-qualified deferred compensation for purposes of
Code §409A be subject to offset, counterclaim or recoupment by any other amount unless otherwise permitted by Code §409A. 
  

	 	17.	Governing Law.  

 This Agreement shall be governed by, and construed, interpreted
and enforced in accordance with the laws of the State of Texas as applied to agreements entirely entered into and performed in Texas by Texas residents exclusive of the conflict of laws provisions of any other state. 

 

	 	18.	Arbitration.  

 Except as set forth below, any controversy or claim arising out of
or relating to this Agreement (including, without limitation, as to arbitrability and any disputes with respect to the Executive’s employment with the Company or the termination of such employment), or the breach thereof, shall be settled by
arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association in effect as of the date of filing of the arbitration administered by a person authorized to practice law in the State of Texas and mutually
selected by the Company and the Executive (the “Arbitrator”). If the Company and the Executive are unable to agree upon the Arbitrator within fifteen (15) days, they shall each select an arbitrator within fifteen (15) days, and
the arbitrators selected by the Company and the Executive shall appoint a third arbitrator to act as the Arbitrator within fifteen (15) days (at which point the Arbitrator alone shall judge the controversy or claim). The arbitration hearing
shall commence within ninety (90) calendar days after the Arbitrator is selected, unless the Company and the Executive mutually agree to extend this time period. The arbitration shall take place in Dallas, Texas. The Arbitrator will have full
power to give directions and make such orders as the Arbitrator deems just. Nonetheless, the Arbitrator explicitly shall not have the authority, power, or right to alter, change, amend, modify, add, or subtract from any provision of this Agreement
except pursuant to Section 15. The Arbitrator shall issue a written decision that sets forth the essential findings and conclusions upon which the Arbitrator’s award or decision is based within thirty (30) days after the conclusion of
the arbitration hearing. The agreement to arbitrate will be specifically enforceable. The award rendered by the Arbitrator shall be final and binding (absent fraud or manifest error), and any arbitration award may be enforced by judgment entered in
any court of competent jurisdiction. The Company and the Executive shall each pay one-half (1/2) of the fees of the Arbitrator. Notwithstanding anything set forth above to the contrary, in the event


  
 15 








 
that the Company seeks injunctive relief and/or specific performance to remedy a breach, evasion, violation or threatened violation of this Agreement, the Executive irrevocably waives her right,
if any, to have any such dispute decided by arbitration or in any jurisdiction or venue other than a state or federal court in the State of Texas. For any such action, the Executive further irrevocably consents to the personal jurisdiction of the
state and federal courts in the State of Texas. 
  

	 	19.	WAIVER OF JURY TRIAL.  

 NO PARTY TO THIS AGREEMENT OR ANY ASSIGNEE, SUCCESSOR,
HEIR OR PERSONAL REPRESENTATIVE OF A PARTY SHALL SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM, OR ANY OTHER LITIGATION PROCEDURE BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY OF THE ANCILLARY AGREEMENTS OR THE DEALINGS OR THE
RELATIONSHIP BETWEEN THE PARTIES. NO PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION, IN WHICH A JURY TRIAL HAS BEEN WAIVED, WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT OR HAS NOT BEEN WAIVED. THE PROVISIONS OF THIS SECTION 19 HAVE BEEN FULLY
DISCUSSED BY THE PARTIES HERETO, AND THESE PROVISIONS SHALL BE SUBJECT TO NO EXCEPTIONS. NO PARTY HERETO HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY HERETO THAT THE PROVISIONS OF THIS SECTION 19 WILL NOT BE FULLY ENFORCED IN ALL
INSTANCES. 
 [Remainder of Page Intentionally Left Blank] 

  
 16 








 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date first written above. 
  

			
	ADDUS HEALTHCARE, INC.
		
	By:	 	 /s/ R. Dirk Allison

	Name:	 	R. Dirk Allison
	Title:	 	President & Chief Executive Officer
	
	 /s/ Brenda Belger

	Brenda Belger


 Signature page to Belger Employment Agreement 







 Exhibit A 

Employment Duties 
 The Executive
shall have those duties set forth below in “Chief Human Resource Officer Job Description” and such other duties and responsibilities which are assigned to the Executive by the President and CEO or the Board of Directors and which are
appropriate for the position of the Executive. 
 The Executive shall be subject to the authority of the Board of Directors and shall report directly to the
President and CEO of the Company. The Executive shall also perform such further duties as are incidental to or implied from the foregoing, consistent with the background, training, and qualifications of the Executive or which may be reasonably
determined by the CEO or the Board of Directors to be in the best interests of the Addus HealthCare Group. 
 The Executive shall have the authority to
recommend and implement appropriate corporate policies and procedures, and execute employment, procurement and other appropriate decisions, in each case, commensurate with her role as Chief Human Resource Officer, subject to oversight by the
President and CEO and the Board of Directors. 
 Job Description 

Chief Human Resources Officer 

Addus HealthCare, Inc. 
 Position
Summary 
 The Chief Human Resource Officer (“CHRO”) will be a visionary that will leverage our Human Resources (“HR”) to lead
the Company to the next stage of its evolution. The CHRO will be responsible for providing the strategic vision and leadership for the Company’s human resource function, and directing the development and execution of all HR programs and
initiatives. The CHRO will direct the planning and implementation of enterprise HR systems in support of business operations, and the development of HR solutions to improve business development, service quality and cost control. 

Senior management views HR as a critical competitive advantage and, because of this, the CHRO and the information services department are viewed as
potentially having a significant impact on the Company’s future growth and success. The CHRO will develop an overall HR plan for the Company that will align HR priorities and capabilities with the needs of the business. In carrying out these
responsibilities, the CHRO will work closely with other Company executives, serve as a key member of the senior management team, and communicate the “vision” for human resource services within the Company. The CHRO must be able to develop
and maintain excellent working relationships with the executive team and, in essence, be viewed as a business partner by the users. 
 The CHRO will be
expected to anticipate changes in the business and routinely identify opportunities in human resources to maximize productivity and profitability in all areas. She will serve as a counselor to and catalyst for other senior executives in identifying
areas for HR improvement that will result in operational efficiencies, increased productivity and communications. She will work with other executives in the Company to continually prioritize 







 
the human resource needs of the Company and will recommend specific new HR enhancement and implementation projects. 

Key Responsibilities 
 Strategy &
Planning 
  

	 	•	 	As a member of the senior executive team, support the Company’s strategic and operational governance processes. 

  

	 	•	 	Lead the Humans Resource Department strategic and operational planning process in support of the Company’s objectives, promoting innovation, prioritizing initiatives, and coordinating the evaluation, deployment and
management of current and future HR systems across the organization. 

  

	 	•	 	Establish annual Humans Resource Department objectives, and direct the development and revision of operating policies and procedures. 


 

	 	•	 	Develop and maintain an Humans Resource Department organizational structure and a strong team that supports the HR needs of the business. 


 

	 	•	 	Identify opportunities for the appropriate and cost-effective investment of financial resources in HR systems and resources, including staffing, sourcing, purchasing and in-house development. 


 

	 	•	 	As appropriate, assess and recommend on the improvements/re-engineering of the Humans Resource organization. 

  

	 	•	 	Develop, monitor and control the Humans Resource annual operating and capital budgets, and develop business case justifications and cost/benefit analyses for HR spending and initiatives. 


Acquisition, Development & Deployment 
  

	 	•	 	Coordinate and facilitate consultation with stakeholders to define business and systems opportunities and requirements for new technology implementations. 


 

	 	•	 	Define and communicate Company plans, policies and standards for acquiring, implementing, and operating HR systems. 

  

	 	•	 	Document, present, and communicate human resource project status and budgets in a clear and concise manner both formally and informally. 


Operational Management 
  

	 	•	 	Ensure continuous delivery of HR services through oversight of service level agreements with end users and monitoring of HR systems performance. 









	 	•	 	Ensure HR policies, procedures and systems comply with HIPAA and Sarbanes-Oxley requirements, as well as other applicable laws and regulations. 


 

	 	•	 	Establish lines of control for current and proposed human resource. 

  

	 	•	 	Keep current with trends and issues in HR and the healthcare industry, including current and emerging human resource opportunities and risks pertinent to the current and future interests of the Company. Advise, counsel,
and educate executives and management on the competitive or financial impact of these trends and issues. 

  

	 	•	 	Promote and oversee strategic relationships between internal HR resources and external entities, including government, vendors and partner organizations. 


 

	 	•	 	Direct the recruitment, development and retention of Humans Resource Department staff in accordance with corporate budgetary objectives and personnel policies. 








 Exhibit B 

Bonus 
 The Executive
is eligible to receive a bonus with a target amount of 75% of the Executive’s annual Base Salary during the applicable calendar year (pro-rated for any partial year), based on the Company’s evaluation of the Executive’s performance
compared to established Company and/or individual objectives, in each case, at the discretion of the Compensation Committee of the Board of Directors. The Compensation Committee shall review and establish the objectives and threshold, target and
maximum levels with respect to such objectives annually.